Cloud computing is rapidly growing in importance as life sciences R&D organizations are inundated with data from multiple sources. Computationally complex imaging, modeling and simulation is on the rise—and limited funding and budget are leading pharmaceutical executives to explore employing cloud-based technology solutions.
The business advantages of utilizing cloud computing for R&D are multi-fold: streamlining of operations, increased communication amongst disparate labs, time efficiency, cost savings, and more. But challenges exist, namely: lack of data control, security concerns and compliance issues. What is the right move now—and what is the best way to assess what will be the right direction tomorrow?
Session: Working Together: Team-Oriented Research and Cloud Optimization in R&D
Moderator: Michael Miller, Global Head R&D High Computing Services, PFIZER
Panelists: Judy Huang, Senior Technical Business Analyst, MERCK
Jean-Claude Franchitti, Ph.D., Computer Science Professor, Courant Institute of Mathematical Sciences, NYU
Chris Mason, Ph.D., Head of the Integrative Functional Genomics Laboratory, Professor of Computational Genomics, WEILL-CORNELL
Michael Braverman, VP and Project Leader of Informatics, ROCHE
At the Cloud Computing Congress for Life Sciences, we'll focus on how to manage sensitive information while using cloud-based technologies, and ways to adapt to these collaborative changes. To learn more, download our program brochure.
We hope to see you March 21-22 in Washington, DC! As a reader of the Cloud Computing Congress blog, you get a 15% discount off the standard rate when using code XP1808BLOG to register.
|
Share this article with your social network, just click below to share now!
|
|
|
